Beta Bionics, Inc. (BBNX) PT Raised to $19 at Goldman Sachs

July 15, 2026 6:24 AM

Goldman Sachs analyst David Roman raised the price target on Beta Bionics, Inc. (NASDAQ: BBNX) to $19.00 (from $17.00) while maintaining a Buy rating.

No results found